The Possibility of Cardiac Cell Regeneration
https://reachmd.com/programs/heart-matters/the-possibility-of-cardiac-cell-regeneration/4742/
A growing body of evidence tells us human cardiomyocytes are capable of endogenous regeneration. The concept has been debated in medicine for some time, but as more data accumulate behind this theory, it is very tempting to think about novel treatment strategies. Dr. Stefan Jovinge, director of the
Congress's Efforts To Fight Diabetes
https://reachmd.com/programs/clinicians-roundtable/congresss-efforts-to-fight-diabetes/1769/
Congressman Mark Kirk, vice chair of the congressional diabetes caucus speaks with host Dr. Mark Nolan Hill both about stem cell research and the challenging problem of solving the diabetes epidemic.
Umbilical cord blood transplantation--research
https://reachmd.com/programs/clinicians-roundtable/umbilical-cord-blood-transplantation-research/834/
Current research focuses on increasing the number of stem cells available from each unit of umbilical cord blood. New uses are also being discovered--learn about effort to regrow heart muscle and even neural tissue.
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/fda-disco-two-approvals-alk-positive-non-small-cell-lung-cancer/9775/
FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer.
Watch Expert Insights on Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
https://reachmd.com/programs/medical-industry-feature/watch-expert-insights-on-newly-diagnosed-transplant-ineligible-multiple-myeloma/15204/
Explore the data on a therapy for patients newly diagnosed with multiple myeloma who are ineligible for autologous stem cell transplant.
U.S. Researchers Use Gene Editing to Remove HIV from 100% of Cells
https://reachmd.com/programs/clinicians-roundtable/us-researchers-use-gene-editing-remove-hiv-from-100-cells/8036/
A team of researchers at Temple University, headed by Dr. Kamel Khalili, removed HIV from cells using CRISPR/Cas-9 gene editing. Will this cure AIDS?
The State of the Art in Apheresis
https://reachmd.com/programs/clinicians-roundtable/the-state-of-the-art-in-apheresis/2594/
Join Dr Shira Johnson as she interviews Dr Sergio Torloni from the Mayo Clinic. Dr Torloni is the Medical Director responsible for theraputic apheresis, stem cell manipulation, and treatment of coagulopathies. He is on the cutting edge of this scientific breakthrough technology utilized in research
Will Science Replace Religion?
https://reachmd.com/programs/clinicians-roundtable/will-science-replace-religion/2583/
Why is the US more religious than Western Europe? Why does stem-cell research stir up so much controversy? ReachMD Book Club host Dr. Leslie Lundt welcomes author Taner Edis, PhD to discuss his book, Science and Nonbelief.
Molecular Neurobiology in Spinal Cord Injuries and Strokes
https://reachmd.com/programs/clinicians-roundtable/molecular-neurobiology-in-spinal-cord-injuries-and-strokes/2432/
John A. Kessler MD is Davee Professor of Stem Cell Biology and Chairman of the Davee Department of Neurology, Northwestern University Medical School. He discusses applying molecular neurobiology to clinical problems of spinal cord injury and stroke. Dr. Bruce Bloom hosts.
Diagnosing and Treating CF: What is new?
https://reachmd.com/programs/clinicians-roundtable/diagnosing-and-treating-cf-what-is-new/2099/
Our guest Dr. Rick Moss discuses with host, Dr. Bill Rutenberg current modes of diagnosis, including the genetic basis of CF. This is followed by a discussion of current and future treatments for cystic fibrosis, including lung transplantation, stem cell and gene therapies.